Search clinical trials for: Cohort 4 of Y101D
Total 3747 results
-
Wuhan YZY Biopharma Co., Ltd.Active, not recruitingMetastatic or Locally Advanced Solid TumorsChina
-
Wuhan YZY Biopharma Co., Ltd.Not yet recruitingHER2-Positive Solid Tumors
-
Emergent BioSolutionsCompleted
-
XOMA (US) LLCCompletedCongenital HyperinsulinismUnited Kingdom, United States
-
Wuhan YZY Biopharma Co., Ltd.Unknown
-
MedImmune LLCCompletedHealthyUnited States, Australia, Spain, Germany, Canada, Finland, South Africa, Brazil, Israel
-
Alopexx Vaccine, LLCCompletedPNAG-expressing Pathogenic Microbes VaccineUnited States
-
Kangabio AUSTRALIA LTD PTYNot yet recruitingAdvanced or Metastatic Solid TumorsAustralia
-
Brown UniversityGlaxoSmithKlineCompletedMetastatic Pancreatic CancerUnited States
-
Janssen Research & Development, LLCCompletedRelapsed or Refractory Hodgkin LymphomaFrance, Germany
-
Nuvamid SAMedpace, Inc.; Anapharm; LGDCompletedHealthy VolunteersUnited States
-
RezoluteCompletedCongenital HyperinsulinismUnited States, Denmark, United Kingdom, Russian Federation, Spain, Bulgaria, Canada, Georgia, Germany, Israel, Turkey
-
Arthrosi TherapeuticsCompletedHealthy VolunteersAustralia
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States
-
AmtixBio Co., Ltd.Not yet recruiting
-
Serum Institute of India Pvt. Ltd.PPDCompleted
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Intron Biotechnology, Inc.CompletedAcute Radiation SyndromeKorea, Republic of
-
AO GENERIUMRecruitingALL | B-precursor Acute Lymphoblastic Leukemia | GNR-084Russian Federation
-
Institut Straumann AGActive, not recruiting
-
Centre hospitalier de l'Université de Montréal...Université de MontréalCompleted
-
Arthrosi TherapeuticsCompletedHealthy VolunteersAustralia
-
Chinese PLA General HospitalUnknownRefractory or Relapsed Aggressive r/r B-NHL With Huge Tumor BurdenChina
-
Jeil Pharmaceutical Co., Ltd.Completed
-
PfizerHalozyme TherapeuticsTerminatedHealthy | HypercholesterolemiaBelgium
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Completed
-
PfizerCompleted
-
New Mexico Cancer Care AllianceCompleted
-
Embera NeuroTherapeutics, Inc.National Institute on Drug Abuse (NIDA)CompletedTobacco Use Disorder | Cocaine Use DisorderUnited States
-
Sara ZayedActive, not recruitingAtrophy of Edentulous Mandibular Alveolar RidgeEgypt
-
New Mexico Cancer Care AllianceCompleted
-
XenoPort, Inc.CompletedGastroesophageal Reflux DiseaseUnited States, Canada
-
PfizerRecruitingHealthy ParticipantsUnited States
-
PfizerCompletedNeoplasmsPoland, United States, Spain
-
Fujian Medical University Union HospitalRecruitingRectal Cancer | Radiation OncologyChina
-
Celldex TherapeuticsTerminated
-
Ikena OncologyGilead SciencesTerminatedBreast Cancer | Head and Neck Cancer | Gynecologic Cancer | Colorectal Cancer | Pancreatic Cancer | Gastric Adenocarcinoma | Lung Adenocarcinoma | Advanced Solid TumorUnited States
-
Novartis PharmaceuticalsCompletedPrimary Sjögren's SyndromeUnited States, Hungary, Germany, Switzerland, United Kingdom
-
Candesant Biomedical, Inc.CompletedPrimary Axillary HyperhidrosisUnited States
-
Fondation Santé des Étudiants de FranceRecruitingPsychological DistressFrance
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Genentech, Inc.CompletedMelanomaUnited States
-
University Hospital, BrestRecruitingMyelodysplastic Syndromes | Chromosome Abnormality | Acute Myeloid Leukemia With Multilineage Dysplasia | Myelodysplastic Syndrome With Ring Sideroblasts | Myelodysplastic Anemia | Myelodysplastic Syndrome With Isolated Del(5Q)France
-
Institut Claudius RegaudUnknown
-
International Vaccine InstituteMassachusetts General Hospital; EuBiologics Co.,LtdRecruitingCholera Vaccination ReactionKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Myeloid Leukemia | Genetic Predisposition to Disease
-
University Hospital, BrestRecruitingSystemic Lupus ErythematosusFrance
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedDuchenne Muscular DystrophyCanada
-
University Hospital, ToulouseRecruiting
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States